Hans Clevers
Corporate Officer/Principal at ROCHE HOLDING AG
Network origin in Hans Clevers first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Utrecht
94
| College/University | Other Consumer Services | 94 |
| Public Company | Pharmaceuticals: Major | 37 | |
LSP Management Group BV
 LSP Management Group BV Investment ManagersFinance LSP Management Group BV (LSP) is an independent European venture capital firm which was founded by Martijn Kleijwegt, Frits van der Have and Tom Schwarz in 1998. Headquartered in Amsterdam, the firm provides financing to early- to mid-stage life science companies.
33
| Subsidiary | Investment Managers | 33 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
24
| Subsidiary | Pharmaceuticals: Major | 24 |
The Royal Netherlands Academy of Arts & Sciences
 The Royal Netherlands Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Netherlands Academy of Arts & Sciences provides research services in the field of science and art. The private company is based in Amsterdam, Netherlands and has subsidiaries in Netherlands. The CEO of the Dutch company is Wilma de Koning.
6
| Private Company | Miscellaneous Commercial Services | 6 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.
5
| Private Company | Miscellaneous Commercial Services | 5 |
Hubrecht Organoid Technology Foundation
2
| Private Company | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hans Clevers via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member Chairman Director/Board Member Director/Board Member | |
| ING GROEP N.V. | Major Banks | Director/Board Member Director/Board Member | |
Roche Holdings, Inc.
 Roche Holdings, Inc. Financial ConglomeratesFinance Roche Holdings, Inc. operates as a holding company, which engages in the manufacture and distribution of pharmaceutical and vitamin products. It also provides financial services to other members of the RHI Group and to refinance on the bond or loan markets. The company was founded in 1987 and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member Chairman Chief Executive Officer | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| NN GROUP N.V. | Life/Health Insurance | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree | |
| ZURICH INSURANCE GROUP LTD | Multi-Line Insurance | Chief Executive Officer Director/Board Member | |
| Maastricht University | College/University | Doctorate Degree Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Director of Finance/CFO Compliance Officer Chief Executive Officer Human Resources Officer | |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director/Board Member Chairman General Counsel Director/Board Member | |
| University of Tilburg | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree | |
ING Bank NV
 ING Bank NV Major BanksFinance ING Bank NV engages in the provision of banking, investment, life insurance, and retirement services. It operates through the following segments: Retail Netherlands, Retail Belgium, Retail Germany, Retail Other, Wholesale Banking, and Corporate Line Banking. The Retail Netherlands segment offers current and savings accounts, business lending, mortgages, and other consumer lending in the Netherlands. The Retail Belgium segment focuses in the retail and private banking activities in Belgium and offered services like the Netherland segment. The Retail Germany segment consists of current and savings accounts, mortgages, and other customer lending. The Retail Other segment comprises income from retail banking activities in the rest of the world, including the SME and mid-corporate segments. The Wholesale Banking segment include income from wholesale banking activities (a full range of products is offered from cash management to corporate finance), real estate, and lease. The Corporate Line Banking segment comprises corporate line banking and the run-off portfolio of Real Estate. The company was founded in 1991 and is headquartered in Amsterdam, the Netherlands. | Major Banks | Director/Board Member Director/Board Member | |
| INSEAD | College/University | Director/Board Member Masters Business Admin Masters Business Admin | |
| University of St. Gallen | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Graduate Degree Director/Board Member Undergraduate Degree | |
| University of Amsterdam | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
Triodos Bank NV
 Triodos Bank NV Regional BanksFinance Triodos Bank NV provides commercial banking and lending services to cultural, social, and environmental organizations. It offers personal and business banking services including loans, overdrafts, current, saving, deposit, and reserve accounts. The firm focuses on the renewable energy, social housing, healthcare, fair trade, organic food, farming, and social development fields. The company was founded in 1968 and is headquartered in Utrecht, the Netherlands. | Regional Banks | Director/Board Member Corporate Officer/Principal | |
| Erasmus University Rotterdam | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree Graduate Degree | |
| Vrije Universiteit Amsterdam | College/University | Graduate Degree Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Undergraduate Degree Doctorate Degree | |
| Radboud University Nijmegen | College/University | Doctorate Degree Graduate Degree Doctorate Degree General Counsel | |
Intrexon ActoBiotics NV
 Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member Director/Board Member | |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member Chairman | |
| European Round Table of Industrialists | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
| MERUS N.V. | Biotechnology | Chief Executive Officer Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| ARGENX SE | Pharmaceuticals: Other | Founder Director/Board Member | |
| IMD Scholarship Foundation | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | ||
Stiftung Avenir Suisse
 Stiftung Avenir Suisse Investment Trusts/Mutual FundsMiscellaneous Stiftung Avenir Suisse develops ideas for the sociopolitical and economic development of Switzerland. It comprises of companies and private individuals from all economic branches and regions of Switzerland. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Economiesuisse
 Economiesuisse Medical/Nursing ServicesHealth Services Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Medical Distributors | Chairman Corporate Officer/Principal | |
Roche Diagnostics AG
 Roche Diagnostics AG Medical SpecialtiesHealth Technology Part of Novartis AG, Roche Diagnostics AG is a Swiss healthcare company committed to improving lives through innovative medicines and diagnostic tests. The company is based in Rotkreuz, Switzerland. Roche has been a pioneer in healthcare since its founding in 1896 and has helped millions of patients worldwide. | Medical Specialties | Director of Finance/CFO Chief Executive Officer | |
Roche Deutschland Holding GmbH
 Roche Deutschland Holding GmbH Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Deutschland Holding GmbH is a German company that manufactures and distributes pharmaceutical products. The company is based in Grenzach-Wyhlen, Germany. The company was founded in 1997 by Fritz Hoffmann-La Roche. The CEO is Claudia Fleischer. Roche Deutschland Holding was acquired by NEXUS AG on November 30, 2018. | Pharmaceuticals: Major | President Corporate Officer/Principal Chief Executive Officer | |
Roche Pharma AG
 Roche Pharma AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma AG is a world leader in innovative cancer drugs and has brought many highly effective drugs onto the market. The company is based in Grenzach-Wyhlen, Germany. The German company also focuses on viral infections, metabolic, central nervous system disorders, and inflammatory diseases. Roche Diagnostics, a subsidiary of Roche Pharma, develops diagnostic tests, instruments, and digital solutions to transform healthcare globally. Roche has been committed to improving lives since its founding in 1896 and creates innovative medicines and diagnostic tests that help millions of patients worldwide. | Medical Distributors | Director/Board Member Chairman | |
NN Insurance Eurasia NV
 NN Insurance Eurasia NV Financial ConglomeratesFinance Part of NN Group NV, NN Insurance Eurasia NV is a Dutch company that functions as an investment holding company. The company is based in The Hague, Netherlands. | Financial Conglomerates | Director/Board Member Director/Board Member | |
LSP Advisory BV
 LSP Advisory BV Investment ManagersFinance Part of LSP Advisory Group BV, EQT Life Sciences is a healthcare investment firm based in Amsterdam, Netherlands. EQT Life Sciences has been connecting investors to inventors in the healthcare sector for over 30 years. The Dutch company has invested in close to two hundred private companies, raising billions of additional capital directed at supporting their R & D. EQT Life Sciences believes in fostering life and constant innovation in healthcare to achieve that goal. The company was founded in 1998, and Mark A. Wegter has been the CEO since then. Recently, EQT Life Sciences was acquired by EQT AB, one of the largest private equity firms in Europe, and among the top-ten private equity firms globally. | Investment Managers | Director/Board Member Chief Executive Officer Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
Roche Diagnostics International AG
 Roche Diagnostics International AG Medical SpecialtiesHealth Technology Part of Roche Holding AG, Roche Diagnostics International AG is a Swiss company that manufactures and supplies diagnostic systems. The company is based in Rotkreuz, Switzerland. | Medical Specialties | Corporate Officer/Principal Chief Executive Officer | |
Roche Diagnostics Deutschland GmbH
 Roche Diagnostics Deutschland GmbH Medical/Nursing ServicesHealth Services Part of Roche Holding AG, Roche Diagnostics Deutschland GmbH is a German company that provides medical and diagnostic services. The company is based in Mannheim, Germany. The CEOs of the company are Christian Paetzke, Dirk Schick, Matthias Pohlmeier. | Medical/Nursing Services | Chairman Corporate Officer/Principal | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
EQT Life Sciences Group BV
 EQT Life Sciences Group BV Investment ManagersFinance EQT Life Sciences Group BV (EQT Life Sciences) is a venture capital firm, a subsidiary of EQT AB founded in 2022 after the acquisition of LSP by EQT. The firm is headquartered in Amsterdam, the Netherlands. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Director of Finance/CFO Private Equity Investor Private Equity Investor Private Equity Investor General Counsel | |
| OCULIS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The Confederation of Netherlands Industry Employers
 The Confederation of Netherlands Industry Employers Miscellaneous Commercial ServicesCommercial Services The Confederation of Netherlands Industry Employers, also known as VNO-NCW, is the largest employers' organization in the Netherlands. The private company is based in The Hague, Netherlands. It represents the interests of Dutch businesses both domestically and internationally and offers various services to its members. The organization advocates for businesses of all sizes and sectors, from AEX companies to family-owned businesses, small and medium-sized enterprises, and young entrepreneurs. VNO-NCW aims to create an environment that fosters entrepreneurship. The organization provides a platform for entrepreneurs to voice their opinions on new legislation and current business issues through the MKB Ondernemerspanel. VNO-NCW also publishes an opinion magazine called Forum, which is free online and available in print for a fee. The organization has expressed support for the government's balanced climate plans, emphasizing the importance of focusing on the execution of all necessary prerequisites to achieve the 2030 climate goals, such as permits and energy infrastructure. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member |
Statistics
International
| Netherlands | 24 |
| Switzerland | 15 |
| Germany | 7 |
| United States | 5 |
| Belgium | 3 |
Sectoral
| Health Technology | 16 |
| Consumer Services | 14 |
| Finance | 12 |
| Commercial Services | 5 |
| Health Services | 3 |
Operational
| Director/Board Member | 463 |
| Corporate Officer/Principal | 226 |
| Chairman | 94 |
| Independent Dir/Board Member | 70 |
| Chief Executive Officer | 61 |
Most connected contacts
| Insiders | |
|---|---|
| André S. Hoffmann | 52 |
| Martijn Kleijwegt | 33 |
| Ulf Mark Schneider | 31 |
| René Kuijten | 30 |
| Paul Bulcke | 28 |
| John Bell | 27 |
| Carole Nüchterlein | 27 |
| Christoph Franz | 27 |
| Claudia Dyckerhoff | 26 |
| Gottlieb A. Keller | 26 |
| Peter Voser | 25 |
| Caroline Princen | 24 |
| Severin Schwan | 23 |
| Patrick Frost | 21 |
| John Paul de Koning | 21 |
- Stock Market
- Insiders
- Hans Clevers
- Company connections
